The International Continence Society (ICS) defines urinary incontinence as every involuntary leakage of urine, i.e., when it is not (always) possible for patients to control the time and place of urination. Furthermore, the ICS differentiates several forms as outlined below.
Urinary incontinence - products
Products for the treatment of overactive bladder and neurogenic detrusor overactivity
Medications known as urologic spasmolytic agents (anticholinergics/antimuscarinics) can be used for the drug treatment of overactive bladder/urge urinary incontinence and neurogenic detrusor overactivity. These calm the bladder musculature and increase bladder capacity.
Anticholinergics are prescription drugs. Therefore, medical consultation is essential before starting this treatment
Products for the treatment of stress incontinence
In the treatment of stress incontinence, conservative measures – such as pelvic floor exercises – predominate.